Cirena has licensed a University of Colorado Boulder RNA synthesis technology, enabling scalable production of high-purity, 100–400 nt RNA constructs for CRISPR, functional genomics, and RNA therapeutics research.
A University of Warwick study finds AI cancer detection models may rely on statistical correlations rather than true biomarker signals, raising concerns about reliability in clinical pathology applications.
The handheld system supports point-of-care fractional exhaled nitric oxide testing in adults and pediatric patients.
The AI companion analyzes up to five years of personal lab data within the company's patient portal to explain test results and identify health trends.
Researchers have validated an IgG ELISA assay for mpox during an active outbreak in Rwanda, enabling distinction between infection- and vaccine-derived immunity, according to findings published in The Lancet Infectious Diseases.
